Thanks to the comprehensive scope of our global spray drying facilities, KABS is uniquely positioned to provide unparalleled scale-up capabilities, all within one network. From preclinical development to commercial manufacturing, we can provide spray drying services and solutions spanning from grams to tones. Additionally, we have the necessary infrastructure in place to safely spray dry both low- and highly-potent compounds alike, offering biopharma companies a range of capabilities for their APIs. By integrating API development and manufacturing, spray drying, and drug formulation under one roof, KABS provides biopharma companies with end-to-end expertise and experience and continuous support at every step.

With sustainable partnerships in mind, KABS promotes analytical continuity in testing impurity profiles of new drug substances and corresponding new drug products. This is a key component of successful CMC section of regulatory submissions. All analytical testing activities performed at KABS are executed in cGMP compliant facilities audited by Health Canada, USFDA, European QPs. We develop and validate stability indicating test methods for new drugs. KABS is a WHO prequalified Quality Control Laboratory.

As a contract research organization (CRO), KABS provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. KABS provides such services as biopharmaceutical development, biological assay development, commercialization, clinical development, clinical trials management, pharmacovigilance, outcomes research, and real-world evidence.